Mylotarg Intravenous and QT prolongation
Result of checking the interaction of drug Mylotarg Intravenous and disease QT prolongation for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:QT interval prolongation has been observed in patients treated with drugs containing calicheamicin. When administering gemtuzumab ozogamicin to patients who have a history of or predisposition for QTc prolongation, who are taking medicinal products that are known to prolong QT interval, and in patients with electrolyte disturbances, obtain electrocardiograms (ECGs) and electrolytes prior to the start of treatment and as needed during administration.
Generic Name: gemtuzumab
Brand Name: Mylotarg
Synonyms: Mylotarg